Suppr超能文献

肺炎克雷伯菌中的多黏菌素耐药性:在存在和不存在质粒编码的磷酸乙醇胺转移酶基因 mcr-1 的情况下使用的多方面机制。

Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1.

机构信息

Department of Microbiology, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

College of Veterinary Medicine, China Agricultural University, Beijing, China.

出版信息

J Antimicrob Chemother. 2019 Nov 1;74(11):3190-3198. doi: 10.1093/jac/dkz314.

Abstract

OBJECTIVES

Until plasmid-mediated mcr-1 was discovered, it was believed that polymyxin resistance in Gram-negative bacteria was mainly mediated by the chromosomally-encoded EptA and ArnT, which modify lipid A with phosphoethanolamine (pEtN) and 4-amino-4-deoxy-l-arabinose (l-Ara4N), respectively. This study aimed to construct a markerless mcr-1 deletion mutant in Klebsiella pneumoniae, validate a reliable reference gene for reverse transcription quantitative PCR (RT-qPCR) and investigate the interactions among mcr-1, arnT and eptA, in response to polymyxin treatments using pharmacokinetics/pharmacodynamics (PK/PD).

METHODS

An isogenic markerless mcr-1 deletion mutant (II-503Δmcr-1) was generated from a clinical K. pneumoniae II-503 isolate. The efficacy of different polymyxin B dosage regimens was examined using an in vitro one-compartment PK/PD model and polymyxin resistance was assessed using population analysis profiles. The expression of mcr-1, eptA and arnT was examined using RT-qPCR with a reference gene pepQ, and lipid A was profiled using LC-MS. In vivo polymyxin B efficacy was investigated in a mouse thigh infection model.

RESULTS

In K. pneumoniae II-503, mcr-1 was constitutively expressed, irrespective of polymyxin exposure. Against II-503Δmcr-1, an initial bactericidal effect was observed within 4 h with polymyxin B at average steady-state concentrations of 1 and 3 mg/L, mimicking patient PK. However, substantial regrowth and concomitantly increased expression of eptA and arnT were detected. Predominant l-Ara4N-modified lipid A species were detected in II-503Δmcr-1 following polymyxin B treatment.

CONCLUSIONS

This is the first study demonstrating a unique markerless deletion of mcr-1 in a clinical polymyxin-resistant K. pneumoniae. The current polymyxin B dosage regimens are suboptimal against K. pneumoniae, regardless of mcr, and can lead to the emergence of resistance.

摘要

目的

在发现质粒介导的 mcr-1 之前,人们认为革兰氏阴性菌的多粘菌素耐药性主要是由染色体编码的 EptA 和 ArnT 介导的,它们分别用磷酸乙醇胺(pEtN)和 4-氨基-4-去氧-l-阿拉伯糖(l-Ara4N)修饰脂 A。本研究旨在构建肺炎克雷伯菌无标记 mcr-1 缺失突变体,验证逆转录定量 PCR(RT-qPCR)的可靠参考基因,并利用药代动力学/药效学(PK/PD)研究多粘菌素处理下 mcr-1、arnT 和 eptA 之间的相互作用。

方法

从临床肺炎克雷伯菌 II-503 分离株中生成无标记 mcr-1 缺失突变体(II-503Δmcr-1)。使用体外一室 PK/PD 模型检查不同多粘菌素 B 剂量方案的疗效,并使用群体分析谱评估多粘菌素耐药性。使用 RT-qPCR 检测 mcr-1、eptA 和 arnT 的表达,参考基因 pepQ,并使用 LC-MS 分析脂 A。在小鼠大腿感染模型中研究体内多粘菌素 B 的疗效。

结果

在肺炎克雷伯菌 II-503 中,mcr-1 持续表达,与多粘菌素暴露无关。针对 II-503Δmcr-1,在多粘菌素 B 平均稳态浓度为 1 和 3mg/L 时,在 4 小时内观察到初始杀菌作用,但随后观察到大量再生,并同时检测到 eptA 和 arnT 的表达增加。在多粘菌素 B 处理后,II-503Δmcr-1 中检测到主要的 l-Ara4N 修饰脂 A 物种。

结论

这是第一项在临床多粘菌素耐药肺炎克雷伯菌中证明独特的无标记 mcr-1 缺失的研究。目前的多粘菌素 B 剂量方案对肺炎克雷伯菌均不理想,无论是否存在 mcr,都可能导致耐药性的出现。

相似文献

引用本文的文献

1
Emergence of drug-resistant phylogroups ( and ) causing human infections.导致人类感染的耐药菌系(和)的出现。
Microbiol Spectr. 2025 Sep 2;13(9):e0019825. doi: 10.1128/spectrum.00198-25. Epub 2025 Aug 8.
4
Polyproline peptide targets polysaccharides to collapse biofilms.聚脯氨酸肽靶向多糖以破坏生物膜。
Cell Rep Phys Sci. 2024 Mar 20;5(3). doi: 10.1016/j.xcrp.2024.101869. Epub 2024 Mar 13.
9
Clinical Perspective of Antimicrobial Resistance in Bacteria.细菌耐药性的临床视角
Infect Drug Resist. 2022 Mar 2;15:735-746. doi: 10.2147/IDR.S345574. eCollection 2022.

本文引用的文献

1
The rise and spread of plasmid-mediated polymyxin resistance.质粒介导的多粘菌素耐药性的出现和传播。
Crit Rev Microbiol. 2019 Mar;45(2):131-161. doi: 10.1080/1040841X.2018.1492902. Epub 2019 May 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验